MAIA Biotechnology, Inc.
MAIA · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $10,009 | $11,112 | $8,933 | $3,453 |
| G&A Expenses | $6,948 | $9,070 | $6,144 | $4,290 |
| SG&A Expenses | $6,948 | $9,070 | $6,144 | $4,290 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $1,099 | $44 |
| Operating Expenses | $16,957 | $20,182 | $16,176 | $7,787 |
| Operating Income | -$16,957 | -$20,182 | -$16,176 | -$7,787 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$6,297 | $409 | $407 | -$4,792 |
| Pre-Tax Income | -$23,255 | -$19,773 | -$15,769 | -$12,578 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23,255 | -$19,773 | -$15,769 | -$12,504 |
| % Margin | – | – | – | – |
| EPS | -1.05 | -1.49 | -1.7 | -1.18 |
| % Growth | 29.5% | 12.4% | -44.1% | – |
| EPS Diluted | -1.05 | -1.49 | -1.7 | -1.18 |
| Weighted Avg Shares Out | 22,198 | 13,262 | 9,277 | 10,636 |
| Weighted Avg Shares Out Dil | 22,198 | 13,262 | 9,277 | 10,636 |
| Supplemental Information | – | – | – | – |
| Interest Income | $318 | $28 | $2 | $2 |
| Interest Expense | $0 | $0 | $7 | $828 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$23,255 | -$19,766 | -$15,762 | -$11,751 |
| % Margin | – | – | – | – |